$CME

CME Q3 Revenue Reaches Record $1.74 Billion as Net Income Hits $1.04 Billion

CME Group (CME) reported Q3 2026 revenue of $1.74B, a record, with net income of $1.04B. Earnings per share were $2.89. Clearing fees revenue was $1.4B, and market data revenue hit a record $243M. The company returned nearly $1B to shareholders. Insider and institutional trading activity was noted.

Original reporting
Published Oct 21, 2026, 11:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME Q3 Revenue Reaches Record $1.74 Billion as Net Income Hits $1.04 Billion — source image
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The record revenue and earnings suggest strong underlying market activity, which may encourage investors to increase exposure to CME and similar infrastructure firms.

02

Market read

CME’s earnings beat could boost financial services sector sentiment and support related stocks.

03

What to watch

Rising debt level to $3.4B and potential regulatory scrutiny on clearing activities could temper upside.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

CME Group is the world’s largest derivatives clearinghouse, and its quarterly results are closely watched for insights into market liquidity and trading volume trends.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported record Q3 2026 revenue of $1.74B and net income of $1.04B, the first public disclosure of these numbers.

Expected impact

likely upward pressure as the market prices in the record earnings

Evidence & confidence

Revenue and earnings are well above prior quarters, indicating robust demand for clearing and data services; insider sales are modest relative to the size of the company.

Market effects

Positive earnings may lift other exchange and data‑service providers.

U.S. markets may see a modest gain in financial services indices.

Global traders monitoring clearing‑house health may adjust exposure to related derivatives platforms.

Counterpoint

Insider sales and high dividend payout could signal management confidence in cash flow but also a lack of growth opportunities.

Key entities

  • CME Group

    Global derivatives clearing and market data provider.

Related articles

$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.

$CMEMed

CME Group (CME) Shares Slip Despite Strong Q3 Results; Dividend

CME Group (CME) shares fell 1.2% premarket despite Q3 earnings and revenue beating estimates. Adjusted EPS was $3.02 on revenue of $1.74B, but expenses rose to $595.9M. The dividend yield is 4.04% with a high payout ratio of 95% and negative 3-year dividend growth. CME's GF Score is 88/100, indicating strong fundamentals but financial strength concerns.